癲癇装置の世界市場(~2027年)

【英語タイトル】Global Epilepsy Devices Market Research Report—Forecast till 2027

Market Research Futureが出版した調査資料(MRF21AU009)・商品コード:MRF21AU009
・発行会社(調査会社):Market Research Future
・発行日:2021年3月
・ページ数:90
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(印刷不可、Online Access)USD4,450 ⇒換算¥658,600見積依頼/購入/質問フォーム
Enterprisewide Price(印刷可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

マーケットリサーチフューチャー社は、癲癇装置の世界市場規模が2020年から2027年まで、年平均6.56%成長すると予測しています。本書では、世界の癲癇装置市場を調査対象とし、エグゼクティブサマリー、市場イントロダクション、調査手法、市場動向、市場要因分析、製品種類別(ウェアラブル型装置、従来型装置、埋込型装置)分析、技術別(迷走神経刺激(VNS)、応答性神経刺激、脳深部刺激療法、加速度計)分析、癲癇発作・予測装置別(脳波(EEG)、頭蓋内脳波、表面筋電図(SEMG)、皮膚電気活動(EDA)、心電図(EKG))分析、エンドユーザー別(病院・クリニック、神経センター、在宅医療、その他)分析、地域別(南北アメリカ、ヨーロッパ、アジア太平洋、中東・アフリカ)分析、競争状況、企業情報などを整理しました。
・エグゼクティブサマリー
・市場イントロダクション
・調査手法
・市場動向
・市場要因分析
・癲癇装置の世界市場規模:製品種類別(ウェアラブル型装置、従来型装置、埋込型装置)
・癲癇装置の世界市場規模:技術別(迷走神経刺激(VNS)、応答性神経刺激、脳深部刺激療法、加速度計)
・癲癇装置の世界市場規模:癲癇発作・予測装置別(脳波(EEG)、頭蓋内脳波、表面筋電図(SEMG)、皮膚電気活動(EDA)、心電図(EKG))
・癲癇装置の世界市場規模:エンドユーザー別(病院・クリニック、神経センター、在宅医療、その他)
・癲癇装置の世界市場規模:地域別(南北アメリカ、ヨーロッパ、アジア太平洋、中東・アフリカ)
・競争状況
・企業情報(Boston Scientific Corporation, Medpage Ltd. (Easylink UK), Cerbomed GmbH (TVNS Technologies GmbH), Liva Nova (Cyberonics), Compumedics, Nihon Kohden, MC10, Empatica, Inc, Medtronic Plc, Neuropace, Inc, and Natus Medical Incorporated)

Global Epilepsy Devices Market Research Report—Forecast till 2027

Market Overview
Global Epilepsy Devices Market anticipated record a significant CAGR of 6.56% during the review period of 2020 to 2027. Epilepsy is an incurable disease caused because of neurological complications and necessarily prevalent and repeatedly rising old age population. As per the Mayo Clinic (US), epilepsy is a central nervous system (neurological) disease in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of awareness. The global market growth is attributed to the increasing prevalence of epilepsy amongst the geriatric population, rising cases of brain injuries owing to road accidents, a large patient pool suffering from neurological disorders, and growing research funding in epilepsy.

The global Epilepsy devices market is expected to witness a healthy market owing to the highest market value of USD 551.2 Million in 2019. The expansion of the global epilepsy devices market is driven by a large patient pool suffering from neurological disorders. As per the WHO, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. The inherent and expanding demand for novel therapies to solve epilepsy-related problems is boosting the manufacturers to develop innovative products.

Market Segmentation
Global Epilepsy Devices Market has been categorized into Product Type, Technology, Seizure Detection and Prediction Devices, and End-Use.
In terms of product type, the global epilepsy devices market is classified into wearable devices, conventional devices, and implantable devices. The wearable devices segment is further classified into watches, bracelets, camera devices, mattress devices, anti-suffocation pillows, and others. Based on technology type, the global epilepsy devices market has been divided into vagus nerve stimulation, responsive neurostimulation, deep brain stimulation, and accelerometry.

By seizure detection and prediction devices, the global market has been segmented into electroencephalogram, intracranial EEG, surface electromyography, electrodermal activity, electrocardiography, video detection systems, implanted advisory systems, and others. Based on the end-user segment, the global epilepsy devices market has been segregated into hospitals & clinics, neurology centers, home care settings, and others.

Regional Analysis
Geographically, the Global Epilepsy Devices Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is expected to lead the global epilepsy devices market due to a large number of companies operating in the region, government regulations, and the increasing healthcare expenditure in the region. The region accounted for a considerable market share of 40.3% in the global epilepsy devices market.

Europe is expected to register the second largest market of the global epilepsy devices market during the forecast period, due to the availability of reimbursement, rising geriatric population prone to epilepsy, and technological advancements in therapeutic devices. Additionally, the presence of highly developed healthcare infrastructure and the research funds from governmental organizations is expected to have a positive impact on the European epilepsy devices market.

Asia-Pacific is expected to register the fastest growing market owing to the increasing population, rising number of patients suffering from epilepsy, the growing awareness about the available treatment options, and strategic decisions by key players operating in the region. The market for epilepsy devices is increasing in the Middle East and Africa (MEA) owing to rising product launches in the region.

Major Players
The Key Players in the Global Epilepsy Devices Market are Boston Scientific Corporation, Medpage Ltd. (Easylink UK), Cerbomed GmbH (TVNS Technologies GmbH), Liva Nova (Cyberonics), Compumedics, Nihon Kohden, MC10, Empatica, Inc, Medtronic Plc, Neuropace, Inc, and Natus Medical Incorporated.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

❖ レポートの目次 ❖

TABLE OF CONTENT
1 EXECUTIVE SUMMARY

1.1 OVERVIEW 17

1.2 MARKET ATTRACTIVENESS ANALYSIS 18

1.2.1 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE 18

1.2.1.1 GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES 19

1.2.2 GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY 20

1.2.3 GLOBAL EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES 21

1.2.4 GLOBAL EPILEPSY DEVICES MARKET, BY END USE 22

1.2.5 GLOBAL EPILEPSY DEVICES MARKET, BY REGION 23

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 24

2.2 RESEARCH OBJECTIVE 24

2.3 MARKET STRUCTURE 25

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS 26

3.2 PRIMARY RESEARCH 27

3.3 SECONDARY RESEARCH 28

3.4 MARKET SIZE ESTIMATION 28

3.5 FORECAST MODEL 30

3.6 LIST OF ASSUMPTIONS & LIMITATIONS 31

4 MARKET DYNAMICS

4.1 INTRODUCTION 32

4.2 DRIVERS 33

4.2.1 RISING PREVALENCE OF EPILEPSY AMONGST THE GERIATRIC POPULATION 33

4.2.2 INCREASING CASES OF BRAIN INJURIES DUE TO ROAD ACCIDENTS 33

4.2.3 RISING NEUROLOGICAL DISORDERS 33

4.2.4 INCREASING RESEARCH FUNDING IN EPILEPSY 34

4.2.5 DRIVERS IMPACT ANALYSIS 34

4.3 RESTRAINTS 35

4.3.1 LOSS OF PATENT PROTECTION FOR BRANDED DRUGS 35

4.3.2 HIGH COSTS ASSOCIATED WITH THE TREATMENT OF EPILEPSY 35

4.3.3 RESTRAINTS IMPACT ANALYSIS 35

4.4 OPPORTUNITIES 36

4.4.1 ENTERING DEVELOPING ECONOMIES 36

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN 37

5.1.1 RESEARCH & DEVELOPMENT AND DESIGNING 37

5.1.2 MANUFACTURING 37

5.1.3 DISTRIBUTION & SALES 37

5.1.4 POST-SALES SERVICES 38

5.2 PORTER’S FIVE FORCES MODEL 38

5.2.1 THREAT OF NEW ENTRANTS 38

5.2.2 BARGAINING POWER OF SUPPLIERS 39

5.2.3 THREAT OF SUBSTITUTES 39

5.2.4 BARGAINING POWER OF BUYERS 39

5.2.5 INTENSITY OF RIVALRY 39

5.3 IMPACT OF COVID-19 ON THE GLOBAL EPILEPSY DEVICES MARKET 39

5.3.1 OVERVIEW 39

5.3.2 IMPACT ON SUPPLY CHAIN 40

5.3.3 IMPACT ON PRODUCTION/MANUFACTURERS 40

5.3.4 IMPACT ON REGIONS 40

5.3.5 IMPACT ON DEMAND 40

6 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE

6.1 INTRODUCTION 41

6.2 WEARABLE DEVICES 42

6.2.1 WATCHES 43

6.2.2 BRACELETS 43

6.2.3 CAMERA DEVICES 43

6.2.4 MATTRESS DEVICES 44

6.2.5 ANTI-SUFFOCATION PILLOWS 44

6.2.6 OTHERS 44

6.3 CONVENTIONAL DEVICES 45

6.4 IMPLANTABLE DEVICES 45

7 GLOBAL EPILEPSY DEVICES MARKET BY TECHNOLOGY

7.1 OVERVIEW 46

7.2 VAGUS NERVE STIMULATION (VNS) 47

7.3 RESPONSIVE NEUROSTIMULATION 47

7.4 DEEP BRAIN STIMULATION 48

7.5 ACCELEROMETRY 48

8 GLOBAL EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND

PREDICTION DEVICES

8.1 OVERVIEW 49

8.2 ELECTROENCEPHALOGRAM (EEG) 50

8.3 INTRACRANIAL EEG 51

8.4 SURFACE ELECTROMYOGRAPHY (SEMG) 51

8.5 ELECTRODERMAL ACTIVITY (EDA) 51

8.6 ELECTROCARDIOGRAPHY (EKG) 52

8.7 VIDEO DETECTION SYSTEMS 52

8.8 IMPLANTED ADVISORY SYSTEMS 53

8.9 OTHERS 53

9 GLOBAL EPILEPSY DEVICES MARKET, BY END USE

9.1 OVERVIEW 54

9.2 HOSPITALS & CLINICS 55

9.3 NEUROLOGY CENTERS 55

9.4 HOME CARE SETTINGS 56

9.5 OTHERS 56

10 GLOBAL EPILEPSY DEVICES MARKET, BY REGION

10.1 INTRODUCTION 57

10.2 AMERICAS 58

10.2.1 NORTH AMERICA 61

10.2.1.1 US 64

10.2.1.2 CANADA 66

10.2.2 LATIN AMERICA 68

10.3 EUROPE 70

10.3.1 WESTERN EUROPE 73

10.3.1.1 GERMANY 76

10.3.1.2 FRANCE 78

10.3.1.3 UK 80

10.3.1.4 ITALY 82

10.3.1.5 SPAIN 84

10.3.1.6 REST OF WESTERN EUROPE 86

10.3.2 EASTERN EUROPE 88

10.4 ASIA-PACIFIC 90

10.4.1 CHINA 93

10.4.2 INDIA 95

10.4.3 JAPAN 97

10.4.4 AUSTRALIA 99

10.4.5 SOUTH KOREA 101

10.4.6 REST OF ASIA-PACIFIC 103

10.5 MIDDLE EAST & AFRICA 105

10.5.1 MIDDLE EAST 108

10.5.2 AFRICA 110

11 COMPETITIVE LANDSCAPE

11.1 COMPETITIVE OVERVIEW 112

11.2 COMPETITOR DASHBOARD 112

11.3 MARKET SHARE ANALYSIS 113

11.4 MAJOR GROWTH STRATEGIES IN THE GLOBAL EPILEPSY DEVICES MARKET 114

11.5 COMPETITIVE BENCHMARKING 115

11.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL EPILEPSY DEVICES MARKET 116

11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 117

11.7.1 PRODUCT DEVELOPMENTS/LAUNCHES 117

11.7.2 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES 118

11.8 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 118

11.8.1 SALES & OPERATING INCOME 118

11.8.2 R&D EXPENDITURE 119

12 COMPANY PROFILES

12.1 BOSTON SCIENTIFIC CORPORATION 120

12.1.1 COMPANY OVERVIEW 120

12.1.2 FINANCIAL OVERVIEW 121

12.1.3 PRODUCTS/SERVICES OFFERED 122

12.1.4 KEY DEVELOPMENTS 122

12.1.5 SWOT ANALYSIS 123

12.1.6 KEY STRATEGIES 123

12.2 MEDPAGE LTD. (EASYLINK UK) 124

12.2.1 COMPANY OVERVIEW 124

12.2.2 FINANCIAL OVERVIEW 124

12.2.3 PRODUCTS/SERVICES OFFERED 124

12.2.4 KEY DEVELOPMENTS 125

12.2.5 SWOT ANALYSIS 125

12.2.6 KEY STRATEGIES 125

12.3 CERBOMED GMBH (TVNS TECHNOLOGIES GMBH) 126

12.3.1 COMPANY OVERVIEW 126

12.3.2 FINANCIAL OVERVIEW 126

12.3.3 PRODUCTS/SERVICES OFFERED 126

12.3.4 KEY DEVELOPMENTS 126

12.3.5 SWOT ANALYSIS 127

12.3.6 KEY STRATEGIES 127

12.4 LIVA NOVA (CYBERONICS) 128

12.4.1 COMPANY OVERVIEW 128

12.4.2 FINANCIAL OVERVIEW 129

12.4.3 PRODUCTS/SERVICES OFFERED 129

12.4.4 KEY DEVELOPMENTS 130

12.4.5 SWOT ANALYSIS 130

12.4.6 KEY STRATEGIES 130

12.5 COMPUMEDICS 131

12.5.1 COMPANY OVERVIEW 131

12.5.2 FINANCIAL OVERVIEW 131

12.5.3 PRODUCTS/SERVICES OFFERED 132

12.5.4 KEY DEVELOPMENTS 132

12.5.5 SWOT ANALYSIS 133

12.5.6 KEY STRATEGIES 133

12.6 NIHON KOHDEN 134

12.6.1 COMPANY OVERVIEW 134

12.6.2 FINANCIAL OVERVIEW 135

12.6.3 PRODUCTS/SERVICES OFFERED 136

12.6.4 KEY DEVELOPMENTS 136

12.6.5 SWOT ANALYSIS 137

12.6.6 KEY STRATEGIES 137

12.7 MC10 138

12.7.1 COMPANY OVERVIEW 138

12.7.2 FINANCIAL OVERVIEW 138

12.7.3 PRODUCTS/SERVICES OFFERED 138

12.7.4 KEY DEVELOPMENTS 138

12.7.5 SWOT ANALYSIS 139

12.7.6 KEY STRATEGIES 139

12.8 EMPATICA, INC. 140

12.8.1 COMPANY OVERVIEW 140

12.8.2 FINANCIAL OVERVIEW 140

12.8.3 PRODUCTS/SERVICES OFFERED 140

12.8.4 KEY DEVELOPMENTS 140

12.8.5 SWOT ANALYSIS 141

12.8.6 KEY STRATEGIES 141

12.9 MEDTRONIC PLC 142

12.9.1 COMPANY OVERVIEW 142

12.9.2 FINANCIAL OVERVIEW 143

12.9.3 PRODUCTS/SERVICES OFFERED 143

12.9.4 KEY DEVELOPMENTS 144

12.9.5 SWOT ANALYSIS 144

12.9.6 KEY STRATEGIES 144

12.10 NEUROPACE, INC. 145

12.10.1 COMPANY OVERVIEW 145

12.10.2 FINANCIAL OVERVIEW 145

12.10.3 PRODUCTS/SERVICES OFFERED 145

12.10.4 KEY DEVELOPMENTS 145

12.10.5 SWOT ANALYSIS 146

12.10.6 KEY STRATEGIES 146

12.11 NATUS MEDICAL INCORPORATED 147

12.11.1 COMPANY OVERVIEW 147

12.11.2 FINANCIAL OVERVIEW 148

12.11.3 PRODUCTS/SERVICES OFFERED 149

12.11.4 KEY DEVELOPMENTS 149

12.11.5 SWOT ANALYSIS 150

12.11.6 KEY STRATEGIES 150

13 APPENDIX

13.1 REFERENCES 151″

LIST OF TABLES

TABLE 1 PRIMARY INTERVIEWS 27

TABLE 2 LIST OF ASSUMPTIONS & LIMITATIONS 31

TABLE 3 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 41

TABLE 4 GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 5 GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 42

TABLE 6 GLOBAL EPILEPSY DEVICES MARKET, BY WATCHES, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 7 GLOBAL EPILEPSY DEVICES MARKET, BY BRACELETS, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 8 GLOBAL EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 9 GLOBAL EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 10 GLOBAL EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 11 GLOBAL EPILEPSY DEVICES MARKET, BY OTHERS, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 12 GLOBAL EPILEPSY DEVICES MARKET, BY CONVENTIONAL DEVICES, BY REGION, 2020–2027 (USD MILLION) 45

TABLE 13 GLOBAL EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, BY REGION, 2020–2027 (USD MILLION) 45

TABLE 14 GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 46

TABLE 15 GLOBAL EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION (VNS), BY REGION, 2020–2027 (USD MILLION) 47

TABLE 16 GLOBAL EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 17 GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 18 GLOBAL EPILEPSY DEVICES MARKET, BY ACCELEROMETRY, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 19 GLOBAL EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 49

TABLE 20 GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM (EEG), BY REGION, 2020–2027 (USD MILLION) 50

TABLE 21 GLOBAL EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 22 GLOBAL EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY (SEMG), BY REGION, 2020–2027 (USD MILLION) 51

TABLE 23 GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM (EEG), BY REGION, 2020–2027 (USD MILLION) 51

TABLE 24 GLOBAL EPILEPSY DEVICES MARKET BY ELECTROCARDIOGRAPHY (EKG), BY REGION, 2020–2027 (USD MILLION) 52

TABLE 25 GLOBAL EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 52

TABLE 26 GLOBAL EPILEPSY DEVICES MARKET BY IMPLANTED ADVISORY SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 27 GLOBAL EPILEPSY DEVICES MARKET, BY OTHERS, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 28 GLOBAL EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 54

TABLE 29 GLOBAL EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION) 55

TABLE 30 GLOBAL EPILEPSY DEVICES MARKET BY NEUROLOGY CENTERS, BY REGION, 2020–2027 (USD MILLION) 55

TABLE 31 GLOBAL EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 32 GLOBAL EPILEPSY DEVICES MARKET, BY OTHERS, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 33 GLOBAL EPILEPSY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 57

TABLE 34 AMERICAS: EPILEPSY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 58

TABLE 35 AMERICAS: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 58

TABLE 36 AMERICAS: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 37 AMERICAS: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 59

TABLE 38 AMERICAS: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 60

TABLE 39 AMERICAS: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 60

TABLE 40 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 61

TABLE 41 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 61

TABLE 42 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 43 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 62

TABLE 44 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,

2020–2027 (USD MILLION) 63

TABLE 45 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 63

TABLE 46 US: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 64

TABLE 47 US: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 48 US: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 64

TABLE 49 US: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 65

TABLE 50 US: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 65

TABLE 51 CANADA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 66

TABLE 52 CANADA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 53 CANADA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 66

TABLE 54 CANADA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 67

TABLE 55 CANADA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 67

TABLE 56 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 68

TABLE 57 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 58 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 68

TABLE 59 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 69

TABLE 60 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 69

TABLE 61 EUROPE: EPILEPSY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 70

TABLE 62 EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 70

TABLE 63 EUROPE: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 64 EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 71

TABLE 65 EUROPE: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 72

TABLE 66 EUROPE: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 72

TABLE 67 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 73

TABLE 68 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 73

TABLE 69 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 70 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 74

TABLE 71 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,

2020–2027 (USD MILLION) 75

TABLE 72 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 75

TABLE 73 GERMANY: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 76

TABLE 74 GERMANY: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 75 GERMANY: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 76

TABLE 76 GERMANY: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 77

TABLE 77 GERMANY: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 77

TABLE 78 FRANCE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 78

TABLE 79 FRANCE: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 80 FRANCE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 78

TABLE 81 FRANCE: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 79

TABLE 82 FRANCE: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 79

TABLE 83 UK: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 80

TABLE 84 UK: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 85 UK: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 80

TABLE 86 UK: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 81

TABLE 87 UK: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 81

TABLE 88 ITALY: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 82

TABLE 89 ITALY: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 90 ITALY: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 82

TABLE 91 ITALY: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 83

TABLE 92 ITALY: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 83

TABLE 93 SPAIN: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 84

TABLE 94 SPAIN: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 95 SPAIN: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 84

TABLE 96 SPAIN: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 85

TABLE 97 SPAIN: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 85

TABLE 98 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 86

TABLE 99 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 100 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 86

TABLE 101 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,

2020–2027 (USD MILLION) 87

TABLE 102 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 87

TABLE 103 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 88

TABLE 104 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 105 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 88

TABLE 106 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,

2020–2027 (USD MILLION) 89

TABLE 107 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 89

TABLE 108 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90

TABLE 109 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 90

TABLE 110 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 111 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 91

TABLE 112 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 92

TABLE 113 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 92

TABLE 114 CHINA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 93

TABLE 115 CHINA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 116 CHINA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 93

TABLE 117 CHINA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 94

TABLE 118 CHINA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 94

TABLE 119 INDIA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 95

TABLE 120 INDIA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 121 INDIA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 95

TABLE 122 INDIA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 96

TABLE 123 INDIA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 96

TABLE 124 JAPAN: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 97

TABLE 125 JAPAN: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 126 JAPAN: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 97

TABLE 127 JAPAN: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 98

TABLE 128 JAPAN: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 98

TABLE 129 AUSTRALIA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 99

TABLE 130 AUSTRALIA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 131 AUSTRALIA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 99

TABLE 132 AUSTRALIA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 100

TABLE 133 AUSTRALIA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 100

TABLE 134 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 101

TABLE 135 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 136 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 101

TABLE 137 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 102

TABLE 138 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 102

TABLE 139 REST OF ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 103

TABLE 140 REST OF ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 141 REST OF ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 103

TABLE 142 REST OF ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,

2020–2027 (USD MILLION) 104

TABLE 143 REST OF ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 104

TABLE 144 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 105

TABLE 145 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 105

TABLE 146 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 106

TABLE 147 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 106

TABLE 148 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,

2020–2027 (USD MILLION) 107

TABLE 149 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 107

TABLE 150 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 108

TABLE 151 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 152 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 108

TABLE 153 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 109

TABLE 154 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 109

TABLE 155 AFRICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 110

TABLE 156 AFRICA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 110

TABLE 157 AFRICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 110

TABLE 158 AFRICA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 111

TABLE 159 AFRICA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 111

TABLE 160 COMPETITOR DASHBOARD: GLOBAL EPILEPSY DEVICES MARKET 112

TABLE 161 THE MOST ACTIVE PLAYERS IN THE GLOBAL EPILEPSY DEVICES MARKET 116

TABLE 162 PRODUCT DEVELOPMENTS/LAUNCHES 117

TABLE 163 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/JOINT VENTURES 118

TABLE 164 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED 122

TABLE 165 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS 122

TABLE 166 MEDPAGE LTD: PRODUCTS/SERVICES OFFERED 124

TABLE 167 CEREBOMED GMBH: PRODUCTS/SERVICES OFFERED 126

TABLE 168 LIVANOVA: PRODUCTS/SERVICES OFFERED 129

TABLE 169 COMPUMEIDCS: PRODUCTS/SERVICES OFFERED 132

TABLE 170 NIHON KOHDEN: PRODUCTS/SERVICES OFFERED 136

TABLE 171 NIHON KOHDEN: KEY DEVELOPMENTS 136

TABLE 172 MC10: PRODUCTS/SERVICES OFFERED 138

TABLE 173 EMPATICA, INC.: PRODUCTS/SERVICES OFFERED 140

TABLE 174 EMPATICA, INC.: KEY DEVELOPMENTS 140

TABLE 175 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED 143

TABLE 176 MEDTRONIC PLC: KEY DEVELOPMENTS 144

TABLE 177 NEUROPACE, INC: PRODUCTS/SERVICES OFFERED 145

TABLE 178 NEUROPACE, INC: KEY DEVELOPMENTS 145

TABLE 179 NATUS MEDICAL INCORPORATED: PRODUCTS/SERVICES OFFERED 149

TABLE 180 NATUS MEDICAL INCORPORATED: KEY DEVELOPMENTS 149

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 17

FIGURE 2 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE 18

FIGURE 3 GLOBAL EPILEPSY DEVICES MARKET, BY ELECTRIC WEARABLE DEVICES 19

FIGURE 4 GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY 20

FIGURE 5 GLOBAL EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES 21

FIGURE 6 GLOBAL EPILEPSY DEVICES MARKET, BY END USE 22

FIGURE 7 GLOBAL EPILEPSY DEVICES MARKET ANALYSIS, BY REGION 23

FIGURE 8 GLOBAL EPILEPSY DEVICES MARKET: STRUCTURE 25

FIGURE 9 RESEARCH PROCESS 26

FIGURE 10 TOP-DOWN AND BOTTOM-UP APPROACHES 29

FIGURE 11 MARKET DYNAMICS OVERVIEW: EPILEPSY DEVICES MARKET 32

FIGURE 12 DRIVERS IMPACT ANALYSIS: GLOBAL EPILEPSY DEVICES MARKET 34

FIGURE 13 RESTRAINTS IMPACT ANALYSIS: GLOBAL EPILEPSY DEVICES MARKET 35

FIGURE 14 GLOBAL EPILEPSY DEVICES MARKET: VALUE CHAIN 37

FIGURE 15 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL EPILEPSY DEVICES MARKET 38

FIGURE 16 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION) 41

FIGURE 17 GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020 & 2027 (USD MILLION) 42

FIGURE 18 GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020 & 2027 (USD MILLION) 46

FIGURE 19 GLOBAL EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020 & 2027 (USD MILLION) 50

FIGURE 20 GLOBAL EPILEPSY DEVICES MARKET, BY END USE, 2020 & 2027 (USD MILLION) 55

FIGURE 21 GLOBAL EPILEPSY DEVICES MARKET, BY REGION, 2020 & 2027 (USD MILLION) 57

FIGURE 22 AMERICAS: EPILEPSY DEVICES MARKET SHARE, BY REGION 2020 (%) 58

FIGURE 23 NORTH AMERICA: EPILEPSY DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 61

FIGURE 24 EUROPE: EPILEPSY DEVICES MARKET SHARE, BY REGION 2020 (%) 70

FIGURE 25 WESTERN EUROPE: EPILEPSY DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 73

FIGURE 26 ASIA-PACIFIC: EPILEPSY DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 90

FIGURE 27 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET SHARE, BY REGION 2020 (%) 105

FIGURE 28 MAJOR MANUFACTURERS MARKET SHARE ANALYSIS, 2020 113

FIGURE 29 CONTRACTS & AGREEMENTS: THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL

EPILEPSY DEVICES MARKET 114

FIGURE 30 BENCHMARKING OF MAJOR COMPETITORS 115

FIGURE 31 SALES & OPERATING INCOME 2020 118

FIGURE 32 MAJOR PLAYERS R&D EXPENDITURE 2020 119

FIGURE 33 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 121

FIGURE 34 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 123

FIGURE 35 MEDPAGE LTD.: SWOT ANALYSIS 125

FIGURE 36 CEREBOMED GMBH: SWOT ANALYSIS 127

FIGURE 37 LIVANOVA: FINANCIAL OVERVIEW SNAPSHOT 129

FIGURE 38 LIVANOVA: SWOT ANALYSIS 130

FIGURE 39 COMPUMEDICS: FINANCIAL OVERVIEW SNAPSHOT 131

FIGURE 40 COMPUMEDICS: SWOT ANALYSIS 133

FIGURE 41 NIHON KOHDEN: PRODUCTS/SERVICES OFFERED 135

FIGURE 42 NIHON KOHDEN: SWOT ANALYSIS 137

FIGURE 43 MC10: SWOT ANALYSIS 139

FIGURE 44 EMPATICA, INC.: SWOT ANALYSIS 141

FIGURE 45 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT 143

FIGURE 46 MEDTRONIC PLC: SWOT ANALYSIS 144

FIGURE 47 NEUROPACE, INC: SWOT ANALYSIS 146

FIGURE 48 NATUS MEDICAL INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT 148

FIGURE 49 NATUS MEDICAL INCORPORATED: SWOT ANALYSIS 150

★調査レポート[癲癇装置の世界市場(~2027年)] (コード:MRF21AU009)販売に関する免責事項を必ずご確認ください。
★調査レポート[癲癇装置の世界市場(~2027年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆